Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Wound Infection 1Surgical Wound Infection 1Stomach Neoplasms 1Sarcopenia 1Postoperative Complications 1Polyps 1Phagocyte Bactericidal Dysfunction 1Obesity 1Malnutrition 1Liver Neoplasms 1Barrett Esophagus 1Adenomatous Polyposis Coli 1

Interventions

Colonoscopy 4eicosapentaenoic acid ethyl ester 1Ursodeoxycholic Acid 1Telemedicine 1Suppositories 1Radiotherapy 1Propofol 1Midazolam 1Folic Acid 1Fentanyl 1Fatty Acids, Omega-3 1Endoscopy 1Endoscopic Mucosal Resection 1Eicosapentaenoic Acid 1Docosahexaenoic Acids 1Diet 1Diagnosis 1Cholecystectomy 1Cholecalciferol 1Celecoxib 1Calcium Carbonate 1CVD protocol 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polyps × Docosahexaenoic Acids × Gastrointestinal × Clear all
NCT03806426 2024-04-25

Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis

S.L.A. Pharma AG

Phase 3 Unknown
204 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡